The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
September 20th 2024
The approval enables more convenient flu immunization options for patients.
About Half of Celgene Subjects with Peripheral T-Cell Lymphoma Achieve Complete Response
December 11th 2014Celgene Corporation's study results of romidepsin in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of patients with peripheral T-cell lymphoma showed 51% of patients achieved a complete response, according to a Celgene press release.
Read More